We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.
|Number of pages||7|
|Publication status||Published - Oct 2006|
- pharmaceutical policies
- drug pricing
- reference pricing
Aaserud, M., Dahlgren, A. A., Kosters, J. P., Strum, H., Ramsay, C. R., & Oxman, A. D. (2006). The effects of reference pricing and other drug pricing policies. Regulatory Rapporteur, 3(10), 2-8. http://www.topra.org/regulatory-rapporteur-october-2006